U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)

December 20, 2023

https://www.globenewswire.com/news-release/2023/12/20/2799669/0/en/U-S-Federal-Circuit-Affirms-Earlier-PTAB-Decision-to-Invalidate-All-Claims-of-United-Therapeutics-Patent-No-10-716-793-793-Patent.html

U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)
Liquidia will pursue final FDA approval for YUTREPIA™ (treprostinil) inhalationLiquidia will immediately request that District Court set aside injunction...
https://www.globenewswire.com/news-release/2023/12/20/2799669/0/en/U-S-Federal-Circuit-Affirms-Earlier-PTAB-Decision-to-Invalidate-All-Claims-of-United-Therapeutics-Patent-No-10-716-793-793-Patent.html

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.